As on Thursday, Abivax ADR (NASDAQ: ABVX) started slowly as it slid -2.52% to $134.85, before settling in for the price of $138.34 at the close. Taking a more long-term approach, ABVX posted a 52-week range of $4.77-$148.83.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -1.44%. Meanwhile, its Annual Earning per share during the time was -1.44%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -33.80%. This publicly-traded company’s shares outstanding now amounts to $77.83 million, simultaneously with a float of $68.89 million. The organization now has a market capitalization sitting at $10.51 billion. At the time of writing, stock’s 50-day Moving Average stood at $114.46, while the 200-day Moving Average is $56.90.
Abivax ADR (ABVX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Abivax ADR’s current insider ownership accounts for 11.60%, in contrast to 55.59% institutional ownership.
Abivax ADR (ABVX) Earnings and Revenue Records
Abivax ADR’s EPS decrease for this current 12-month fiscal period is -33.80% and is forecasted to reach -3.62 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -1.21% through the next 5 years, which can be compared against the -1.44% growth it accomplished over the previous five years trading on the market.
Abivax ADR (NASDAQ: ABVX) Trading Performance Indicators
Let’s observe the current performance indicators for Abivax ADR (ABVX). It’s Quick Ratio in the last reported quarter now stands at 7.86.
In the same vein, ABVX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.02, a figure that is expected to reach -1.53 in the next quarter, and analysts are predicting that it will be -3.62 at the market close of one year from today.
Technical Analysis of Abivax ADR (ABVX)
Through scrutinizing the latest numbers posted by the [Abivax ADR, ABVX], it can be observed that its last 5-days Average volume of 1.37 million was better the volume of 0.89 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 71.37% While, its Average True Range was 57.41.
Raw Stochastic average of Abivax ADR (ABVX) in the period of the previous 100 days is set at 82.89%, which indicates a major rise in contrast to 65.33% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 7.27 that was higher than 4.83 volatility it exhibited in the past 100-days period.
